292 results on '"Staumont-Sallé, Delphine"'
Search Results
2. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
3. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab
4. Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
5. Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis
6. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study
7. Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience
8. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
9. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases
10. Pseudoxanthoma elasticum, a difficult diagnostic in patient with dark skin
11. DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series
12. Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
13. “Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients
14. Initial characteristics and follow-up of patients with a confirmed diagnosis of angiotensin-converting enzyme inhibitors-induced angioedema
15. Syndrome de Stevens-Johnson induit par la lymécycline chez un adolescent de 17 ans : cas clinique et revue de la littérature
16. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis
17. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
18. Clinical profile of pathological urticarial vasculitis: A retrospective study.
19. Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis
20. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
21. Atopic dermatitis in elderly adults
22. Immunosuppressants as steroid-sparing agents for chronic DRESS: four cases
23. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis
24. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis
25. Automatic quantification method of eosinophilic degranulation in tissues: Application for the study of eosinophilic disorders
26. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
27. Automatic quantification method of eosinophilic degranulation in tissues: application for the study of eosinophilic disorders
28. P-170 - Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome
29. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study
30. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
31. Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80
32. About two cases of possible topical steroid withdrawal reaction
33. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
34. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
35. ESDR039 - Functional profile of circulating eosinophils in atopic dermatitis
36. Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey
37. 34927 Adverse events associated with dupilumab in the WHO pharmacovigilance
38. Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80
39. Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma
40. Efficacy of combining pulse corticotherapy and methotrexate in alopecia areata: Real‐life evaluation
41. About two cases of possible topical steroid withdrawal reaction
42. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis:pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
43. Patients with Crohnʼs Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab
44. Conduite à tenir devant une hyperéosinophilie.
45. A new epidemic profile for human scabies in a general practice in the city of Tourcoing, northern France
46. Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases
47. Pyoderma gangrenosum developing in a patient treated with dupilumab
48. The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support
49. Caractéristiques en vraie vie et schémas thérapeutiques chez des patients atteints de dermatite atopique en France : résultats de l’enquête de satisfaction et des besoins non-couverts
50. Contrôler la dermatite atopique améliore la prise en charge du patient
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.